ProSciento, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Chula Vista CA Uruguay (2004)

Organization Overview

First Clinical Trial
2010
NCT01201278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hompesch, Marcus, M.D. | ProSciento | ProSciento, Inc.